Abbott Laboratories (ABT) Other Operating Expenses (2009 - 2026)

Abbott Laboratories has disclosed Other Operating Expenses across 18 years of filings, most recently posting $5.3 billion for Q1 2026.

• Other Operating Expenses for Q1 2026 came in at $5.3 billion, up 8.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $21.4 billion (up 4.32% YoY), and the FY2025 annual result was $21.0 billion, up 2.03% from the prior year.
• Other Operating Expenses came in at $5.3 billion for Q1 2026 at Abbott Laboratories, down from $5.3 billion in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $5.5 billion in Q1 2022 to a low of $4.8 billion in Q1 2023.
• The 5-year median for Other Operating Expenses is $5.1 billion (2022), against an average of $5.2 billion.
• Across the five-year window, Other Operating Expenses increased 12.0% in 2022 and dropped 12.31% in 2023, its largest moves.
• Abbott Laboratories' Other Operating Expenses stood at $5.1 billion in 2022, then dropped by 1.02% to $5.0 billion in 2023, then grew by 7.35% to $5.4 billion in 2024, then dropped by 1.17% to $5.3 billion in 2025, then decreased by 0.6% to $5.3 billion in 2026.
• The last three Other Operating Expenses figures came in at $5.3 billion (Q1 2026), $5.3 billion (Q4 2025), and $5.5 billion (Q3 2025), per Business Quant data.